
The latest episode of the Mayo Clinic Q&A podcast, features a milestone in the treatment of cystic fibrosis (CF).
Tim Myer has lived with cystic fibrosis his whole life. He was awaiting a lung transplant, when a new medication approved by the Food and Drug Administration changed everything.
"There are about 30,000 patients in the U.S. with cystic fibrosis. This drug will expand treatment to 27,000, or 90% of all patients with CF in the U.S.," says Dr. Mark Wylam, a Mayo Clinic pulmonologist, and Myer's physician.
Myer and Dr. Wylam share the story on this week's Mayo Clinic Q&A podcast.
Click the media player below:
News Release: Mayo Clinic News Network launches new podcast to help consumers: Mayo Clinic Q&A
When people think of a pharmacist, they usually think of someone dispensing medication. Pharmacists do fill prescriptions, but there's another type of pharmacist who plays ...
Mayo Clinic is among the first in the world to perform a spinal fusion surgery, called TLIF, with robotic assistance and incorporating spinal anesthesia, meaning ...
National Cancer Survivors Day will be observed Sunday, June 4, which makes this a good time to learn more about life after cancer. One in 2 men ...